Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Emerging systemic therapies for atopic dermatitis: oral small molecules and targeted topical agents
By
- AMS
posted
Nov 04, 2020 05:52 AM
0
Recommend
.
0 comments
0 views
Permalink
Related Content
Emerging systemic therapies for atopic dermatitis: biologics
- AMS
Added Nov 04, 2020
Blog Entry
Efficacy of biologics and oral small molecules for atopic dermatitis: a systematic review and meta-analysis
- AMS
Added Oct 08, 2021
Blog Entry
United States systemic psoriasis treatments: increases in the use of biologic agents and plateau of methotrexate and oral small molecule inhibitors
- AMS
Added Feb 20, 2020
Blog Entry
Inadequate response and treatment patterns in adults diagnosed with atopic dermatitis and treated with topical therapy
- AMS
Added Oct 06, 2021
Blog Entry
Punctal stenosis associated with dupilumab therapy for atopic dermatitis
- AMS
Added Jan 08, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic